r/LFWD_Stock

Harsh but Bullish

The LFWD Q2 earnings report has revealed (and for those of us following reassured) that the turnaround is in full effect.

Not only has a strategy been planned,
Not only has the strategy been established,
Not only are they executing,
But it’s working.

And the plan is to continue with the expectation it will only keep getting better.

But one thing that was mentioned in the report and caught some attention was the stepping down of the CFO and some board members.

There could be many explanations, but the way I’m interpreting it is the changing of the guards. The “old guard” that was responsible for the business short comings of LFWD is leaving, and the new guard is taking control.

The previous management (from the CEO and those who left earlier, to those stepping down now) deserve compliments for what they have achieved and developed, and should be thanked for their contributions (and for the opportunity they created for us to now invest at the bottom), but the business fit and expertise needed to take the company forward we’re missing, and now that the turnaround is in full effect it is impacting the company personnel as well.

Not fun to see good people leave, but I’m sure it will turn out for the better for each and every one, and wish them nothing but the best.

This means this company, and the new board coming in (notably Oramed) will go to any length to get this company back on track, which I believe it already is, and to drive it forward.

reddit.com
u/Pristine_Hurry_4693 — 3 days ago

Lifeward Ltd. (Nasdaq: $LFWD): From ReWalk’s Bionic Walking Pioneer to a High-Risk Neurorehabilitation and Biomedical Platform

https://www.merlintrader.com/lifeward-ltd-stock-hub/

Last dated event — reported by the company

Q2 2026 results, August 14, 2026

Revenue rose 16% to $6.623 million, the strongest quarter since the fourth quarter of 2024, and unrestricted cash stood at $9.448 million at June 30, 2026 against approximately $11 million on a pro-forma basis after the July tranche. The same filing disclosed the resignation of three directors effective August 13 and the departure of the chief financial officer effective September 30. The reported net loss widened to $11.519 million because of a $6.912 million non-cash fair-value remeasurement of warrant and derivative liabilities. Figures from the Form 8-K and Exhibit 99.1 filed August 14, 2026, and the Q2 2026 Form 10-Q.

u/Merlin8121 — 6 days ago

Aug 14 Friday morning earning report

Let’s see how the insurance coverage plays out for LFWD

My prediction is Humana and UHC coverage will reflect on the q2 report while Aetna might show up on next report as they started mid February and it takes couple months

Fingers crossed on supply chain recovery for AlterG product too

reddit.com
u/anonmoneyguru — 13 days ago